Hypermethylation of HLA class I gene is associated with HLA class I down‐regulation in human gastric cancer
The DOI matches its Crossref record.
Abstract
Abstract Down‐regulated expression of human leukocyte antigen (HLA) class I molecules in many human cancers facilitate tumor cells to escape from immune attack. Promoter hypermethylation, one of the major epigenetic changes responsible for gene inactivation, plays an important role in gastric carcinogenesis. This study evaluated the expression and alteration of HLA class I molecules in a panel of 47 pairs of gastric cancer specimens with their noncancerous parts from Chinese patients by using immunohistochemistry (IHC), reverse transcription polymerase chain reaction (RT‐PCR) and methylation‐specific PCR (MSP) analysis. The expression of HLA‐A, HLA‐B/C and HLA class I complex was lost or down‐regulated in human gastric cancer. The percentage of promoter methylation was 59.57% for HLA‐A gene, 55.32% for HLA‐B gene and 48.94% for HLA‐C gene in gastric cancer, while it was decreased to 19.15%, 12.77% and 6.38% in the adjacent nontumor tissues, respectively. Seven of 10 (70%), 4 of 6 (66.7%) and 3 of 4 (75%) gastric cancer specimens with promoter hypermethylation at HLA‐A, ‐B and ‐C loci showed transcriptional inactivation of HLA‐A,‐B and ‐C genes, suggesting an association between promoter hypermethylation and down‐regulated expression of HLA class I molecules. Human gastric cancer cell line BGC‐823 showed HLA‐A down‐regulation with promoter methylation of HLA‐A locus. Treatment with DNA methyltransferase inhibitor restored the expression of HLA‐A mRNA and surface HLA‐A complex. Thus, our results showed that promoter hypermethylation might be one of the mechanisms that lead to HLA class I antigen down‐regulation in gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Jhunjhunwala, S., Hammer, C., & Delamarre, L. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00339-z · Cited by 1,490
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Dhatchinamoorthy, K., Colbert, J. D., & Rock, K. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636568 · Cited by 1,077
Epigenetics in cancer stem cells
Toh, T. B., Lim, J. J., & Chow, E. K.-H. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0596-9 · Cited by 422
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Yang, K., Halima, A., & Chan, T. A. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00789-4 · Cited by 321
Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
Taylor, B. C., & Balko, J. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844866 · Cited by 298
Metadata
- Authors
- Ye, Q., Shen, Y., Wang, X., Yang, J., Miao, F., Shen, C., & Zhang, J.
- Venue
- Tissue Antigens
- Publisher
- Wiley
- Published
- 2009-12-15
- Volume
- 75
- Issue
- 1
- Pages
- 30-39
- ISSN
- 0001-2815 (ISSN-L)
- 1399-0039
- OpenAlex
- W2005431410
- Cited by
- 65
- References
- 0
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypermethylation of HLA class I gene is associated with HLA class I down‐regulation in human gastric cancer. https://app.cochat.ai/papers/10.1111/j.1399-0039.2009.01390.x
- The paper
- Ye, Q., Shen, Y., Wang, X., Yang, J., Miao, F., Shen, C., & Zhang, J. (2010). Hypermethylation of HLA class I gene is associated with HLA class I down‐regulation in human gastric cancer. Tissue Antigens. https://doi.org/10.1111/j.1399-0039.2009.01390.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.